Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could extra X-Rays catch more hip issues in At-Risk babies?

NCT ID NCT07066852

Knowledge-focused Sponsor: Ankara City Hospital Bilkent Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study checks if adding X-rays to standard ultrasound screening helps find hip dysplasia earlier in babies with risk factors like being first-born, female, or breech. Researchers will follow 300 infants born in a Turkish hospital, scanning them at 6 weeks, 3 months, 6 months, and 1 year. The goal is to see if extra screening prevents missed cases and later hip pain or arthritis.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that adding X-ray screening to ultrasound helps catch more cases of hip dysplasia early, leading to better outcomes for at-risk infants.
What could go wrong
This is an observational study, not a treatment trial. It may not prove that extra screening improves long-term health, and results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2024

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study will include all children born in the high-risk pregnancy service at our hospital. Participants will be selected randomly, and their families will be informed about the study, providing consent for participation. The study aims to evaluate the effectiveness of developmental hip dysplasia (DDH) screening in high-risk groups in Turkey. Hip ultrasound will be performed six weeks after birth using the Graf method for screening purposes. This examination will include the Ortolani-Barlow test, Galeazzi sign, swaddling, and assessment of any accompanying foot deformities. All ultrasounds will be conducted by a single physician. If any pathology is detected, treatment will be initiated according to current literature. Follow-up evaluations will be conducted at three months, six months, and one year to monitor hip development and assess the acetabular index using Tönnis grading and abduction limitation.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All girls and boys of Turkish origin born in our hospital were included in our study. Exclusion Criteria: * Teratological hip diseases with neuromuscular disorders were excluded from our study. Parents who disrupted follow-up were excluded from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Developmental dysplasia of hip are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

developmental dysplasia of the hip Hip Dislocation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Developmental dysplasia of hip

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Orthopedics and Traumatology, Bilkent City Hospital, Ankara

    Ankara, Ankara, 06340, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.